How I Made $5000 in the Stock Market

Stocks Are Typically Immune to Government Shutdowns. Why It’s Different This Time.

Sep 29, 2025 06:41:00 -0400 | #Markets #The Barron's Daily

(Anna Moneymaker/Getty Images)

The week has barely started and it’s probably not unusual that everyone’s looking forward to Friday already. But there is a twist—it’s not just impatience for the weekend—the market is waiting for data to gauge the strength of the jobs market, but it could be disappointed. The government shutdown might get in the way.

Government shutdowns are typically a political headache rather than an economic one. In the previous six shutdowns lasting five or more trading days, the S&P 500 rose more often than it fell. That means investors would normally brush off the Tuesday night deadline for lawmakers to strike an agreement to keep funding the federal government.

However, a shutdown could delay the publication of September’s jobs report as all nonessential work—including statistical releases—is halted. That’s an issue for a nervous market looking for reassurance that the Federal Reserve is still on track for an extended cycle of interest-rate cuts. A couple of days might not be a huge disruption but a significant shutdown—like the 35-day impasse in President Donald Trump’s first term—would challenge the strength of the bull market.

There are a couple of other data points worth watching this week that could move markets. Tesla’s third-quarter deliveries data are due, in a test for the electric-vehicle maker’s hefty valuation. Meanwhile the pharmaceutical industry faces a Monday deadline to meet the Trump administration’s demands for lower drug prices, and sporting-goods retailer Nike is the pick of the early earnings reports on Tuesday, providing an insight into the effects of tariffs.

Still, the jobs report will be the main event for markets and investors will be hoping for that Friday feeling.

Adam Clark

***Join Barron’s senior managing editor Lauren R. Rublin and associate editor Andrew Bary today at noon when they discuss updates on Berkshire Hathaway, media mergers, investing in sports, the outlook for gold, and more. Sign up here.

***

Federal Government Shutdown a Game of Chicken

Lawmakers were still playing the blame game on Sunday heading into a meeting at the White House today. Both sides are placing the responsibility for any shutdown at each other’s feet. Today’s meeting with President Donald Trump comes as they try to break an impasse with just hours to go.

What’s Next: Trump is going to attend a mystery meeting on Tuesday organized by Defense Secretary Pete Hegseth, who has summoned top Pentagon brass to Washington. Trump told NBC News on Sunday the meeting was to focus on how the Defense Department was doing and “esprit de corps.”

Liz Moyer and Janet H. Cho

***

Jobs Report This Week Faces Possible Disruption

Speaking of a shutdown, a key government report could be delayed if things get thrown up in the air. Friday is supposed to bring the release of the September jobs report, which economists expect to show steady unemployment and a rise in jobs created since the August report.

What’s Next: A shutdown could affect jobs another way. Trump told NBC News in an interview Sunday that he could use a federal shutdown as a reason to cut a lot of jobs on a permanent basis. “[I’d] rather not do that,” he told NBC.

—Dan Lam and Liz Moyer

***

Tesla Reports EV Deliveries This Week. Does It Matter?

Tesla is reporting its third-quarter electric-vehicle deliveries this week, and everyone will be watching to see if they will reverse this year’s trend and show a gain over last year. But investors also have to wonder whether it matters in the long run.

What’s Next: The fourth quarter might not turn out as well as the third quarter. EV sales have been boosted recently by the expiration of the $7,500 federal EV purchase tax credit, which has people buying EVs ahead of the deadline. It goes away at the end of September.

Al Root

***

Deadline Comes Today in Trump’s Big Drug Pricing Initiative

A deadline set by President Donald Trump for pharmaceutical companies to make “binding commitments” to lower U.S. drug prices expires Monday, and now it’s up to the White House to decide whether the industry’s efforts to appease the administration have gone far enough.

What’s Next: It isn’t clear what will actually happen this week, or if drugmakers plan to issue formal responses to the administration, however, a report by the drug industry publication Endpoints News suggested a drug pricing announcement could come that would include new Medicare and Medicaid demonstration programs for new pricing strategies.

Josh Nathan-Kazis

***

Warner Bros. Scores Its Ninth Top Film Debut of 2025

Warner Bros. Discovery extended its hot streak, notching another theatrical debut in the number one spot at the domestic box office. That would be the Hollywood studio’s ninth top debut for the year, putting it well ahead of rival studios and on track to meet or beat its 2011 record.

What’s Next: October’s lineup is also full, Dergarabedian said. A24’s The Smashing Machine, a drama about mixed-martial arts and UFC champion Mark Kerr starring Dwayne Johnson, and Focus Features’ psychological drama Anemone, starring Daniel Day-Lewis, both open on Friday.

—Janet H. Cho

***

—Newsletter edited by Liz Moyer, Rupert Steiner, Callum Keown